What is LOPJLB’s current signal on GRCE?

LOPJLB’s latest quantitative signal on Grace Therapeutics, Inc. (GRCE) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is GRCE in?

Grace Therapeutics, Inc. (GRCE) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Grace Therapeutics, Inc. (GRCE) do?

Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal betame…

Where is Grace Therapeutics, Inc. based / listed?

Grace Therapeutics, Inc. is based in US, listed on NASDAQ.

Grace Therapeutics, Inc. (GRCE)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$2.08+1.96%Close

SELLRECOVERY · day 40

[SCORES & PROFILE]

FUND: 0
VALUE: 0
GROWTH: 43
GARP: 0
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-21.5%

REV YoY-

ROE-1.8%

EPS YoY-

ROA-42.8%

GROSS

NET

[VALUATION]

P/E TTM-1.64

P/E FWD-

SECTOR PE20.47

INDUSTRY PE13.95

P/B0.74

P/FCF-

EV/EBITDA-0.77

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO11.47

ND/EBITDA-

BETA0.37

NET INCOME (TTM) < 0

Grace Therapeutics, Inc. (GRCE)

Key stats

Prediction markets

FUNDAMENTALS

Company news